Beijing Shihong Drug Development Center

Beijing Shihong Drug Development Center is a specialized pharmaceutical research and production entity based in Beijing, China, focusing on advanced wound care and tissue regeneration. Founded by Dr. Zhao Shihong, the center has developed a proprietary line of topical treatments, most notably the Shihong Shengji series, which integrates traditional Chinese medical principles with modern drug development. Its primary products, including ointments and powders, are specifically formulated to treat refractory wounds such as stage III and IV pressure sores, diabetic foot ulcers, and deep burns. The company's therapeutic approach emphasizes promoting granulation tissue growth and accelerating epithelialization in chronic skin lesions. Beijing Shihong Drug Development Center serves a critical niche in the Chinese healthcare market, providing non-invasive alternatives for complex surgical wounds.